HeartBeam, Inc.

HeartBeam, Inc.

BEAT·NASDAQ

$1.47

+8.1%
HealthcareMedical - Healthcare Information Services

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

At a Glance

Live Snapshot
Market Cap$50.63M
EPS-0.6200
P/E Ratio-3.85
Earnings Date05/07/2026

beat

Stock Based Compensation

Last Annual Value

5.15M

3-Year CAGR

66%

5-Year CAGR

249%

10-Year CAGR

%

HeartBeam, Inc.

HeartBeam, Inc. Competitors Analysis of Stock Based Compensation

BEAT · NASDAQ
CompanyStock Based Compensation
CAGR 3Y
CAGR 5Y
CAGR 10Y
BEAT logo
HeartBeam, Inc.
NASDAQ:BEAT
5.15M
17.1%93.0%-2.3% 
2.32M
-16.6%-12.0%N/A
2.57M
-17.7%-8.2%N/A
4.74M
-16.6%-16.3%18.2%
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
3.80M
-9.0%0.7%N/A
0.00
N/AN/AN/A
MNOV logo
MediciNova, Inc.
NASDAQ:MNOV
829.10K
5.3%-13.6%-14.5%
228.00K
-16.2%-50.6%N/A
2.67B
784.8%333.6%N/A
6.25M
-8.0%8.8%N/A
268.30K
N/AN/AN/A
HeartBeam, Inc.

HeartBeam, Inc. Fair Value Envelope

BEAT · NASDAQ

Our analysis suggests that BEAT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.47, this represents a potential HIDDEN relative to our calculated worth for HeartBeam, Inc..

Intrinsic Value
Current Price: $1.47